Early Data: Moderna COVID-19 Vaccine 94.5% Effective

Watch VideoMore promising news in the COVID vaccine race. Early findings show Moderna’s experimental vaccine has worked in nearly 95 percent of patients. 

This vaccine candidate uses a new gene technology called messenger RNA. When injected, the RNA enters healthy cells where it makes coronavirus spike proteins and that...